Navigation Links
Signature Therapeutics Receives BrIDGs Award to Advance Its Abuse-Deterrent Oxycodone, PF614
Date:7/29/2013

PALO ALTO, Calif., July 29, 2013 /PRNewswire/ --  Signature Therapeutics, Inc., a development-stage biopharmaceutical company, announced today that it has received no-cost access to contractor resources through the National Center for Advancing Translational Sciences' Bridging Interventional Development Gaps (BrIDGs) program (part of the NIH) to support development of its extended-release, abuse-deterrent oxycodone, PF614 – a novel, inactive prodrug formulation that must be digested to achieve therapeutic benefit.  NIH's National Institute on Drug Abuse is providing funding directly to BrIDGs to support the project, which includes scale-up synthesis, drug product packaging, pharmacokinetic analysis and IND-enabling toxicology studies.

(Logo:  http://photos.prnewswire.com/prnh/20130729/SF54809LOGO)

Wes Sterman, President and CEO of Signature Therapeutics, commented, "We are grateful to the staff of NIDA and NCATS that saw the value of our abuse-deterrent prodrug technology and which made the decision to provide contractor resources to further our work.  Their support helps validate the importance of the prodrug technology approach in the field of abuse-deterrent opioid drugs, and the potential of the technology to greatly impact the public health crisis of prescription drug abuse.  We look forward to the continued development of PF614, and anticipate the filing of a US IND in the first half of 2014."

About Prescription Drug Abuse

Abuse of prescription drugs is the fastest growing drug problem according to the US Office of National Drug Control Policy (ONDCP).1   The Centers for Disease Control (CDC) has characterized this problem as an epidemi
'/>"/>

SOURCE Signature Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Wacoms New DTU-1031 Provides Paperless Electronic Signature Solution for Businesses
2. CLAAD Lauds Signature Therapeutics R&D Efforts To Reduce Prescription Drug Abuse
3. Cell Therapeutics, Inc. (CTI) to Report First Quarter Financial Results on April 20
4. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing in Chelsea Therapeutics International, Ltd. to Contact the Firm
5. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
6. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
7. Zacks Industry Outlook Highlights: Eli Lilly, Forest Labs, ViroPharma, Novartis and United Therapeutics
8. Oxford BioTherapeutics Appoints Senior Industry Leader to Head its New Clinical Development Operations in Basel, Switzerland
9. Nektar Therapeutics Reports Financial Results for the First Quarter of 2012
10. Cara Therapeutics Licenses Novel Kappa Opioid Agonist, CR845, to Chong Kun Dang Pharmaceutical Corporation For South Korean Market
11. Frost & Sullivan: High Uptake of New Drug Therapies and Aging Population Expansion Keep the U.S. Retinal Therapeutics Market Buoyant
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... , Sep. 03, 2015 ... addition of the "Investigation Report on China Tropisetron ... Tropisetron, developed by Novartis, entered the market in ... the Chinese market in the late 1990s. Tropisetron got ... 1994 after its original developer Sandoz submitted application. But ...
(Date:9/3/2015)... REHOVOT, Israel, Sept. 3, 2015 OticPharma, Ltd., ... innovative therapies for ear, nose, and throat (ENT) disorders, ... Gateway office complex to be the location of its ... by end of September and will have office locations ... OticPharma, Inc. 19900 MacArthur Blvd., Suite 550 ...
(Date:9/2/2015)... 2, 2015 About implantable medical devices ... to replace, augment, or repair damaged tissues or ... of applications including cosmetic, spinal, cardiovascular, ophthalmic, and ... different materials such as polymers, metals, ceramics, and ... medical devices market to grow at a CAGR ...
Breaking Medicine Technology:China Tropisetron (Novartis) Market Report 2015-2019 2OticPharma Establishes U.S. Headquarters in Orange County, California 2Global Implantable Medical Devices Market 2015-2019 2
... Water Street Healthcare Partners , a strategic private ... announced today that it has completed a sale and ... CareCentrix is the nation,s leading provider of ... industry.  Water Street sold its majority interest in CareCentrix ...
... COPENHAGEN, Denmark and LAGUNA NIGUEL, Calif., Sept. 20, ... today announced that the two companies have entered ... manufacture of bulk IB1001, Inspiration,s intravenous recombinant factor ... of bleeding in individuals with hemophilia B. Under ...
Cached Medicine Technology:Water Street Healthcare Partners Completes Sale and Recapitalization of CareCentrix 2Water Street Healthcare Partners Completes Sale and Recapitalization of CareCentrix 3CMC Biologics Enters Commercial Supply Agreement with Inspiration Biopharmaceuticals for IB1001 2CMC Biologics Enters Commercial Supply Agreement with Inspiration Biopharmaceuticals for IB1001 3
(Date:9/3/2015)... ... September 03, 2015 , ... “Love in Tokyo” an independent romantic comedy film ... Amazon and will be released on DVD early next year, by Maverick ... Itsuka, an actress and singer/songwriter, and Jason London, lead from “Dazed and Confused.” ...
(Date:9/3/2015)... ... September 03, 2015 , ... When looking at the types of people who have ... of two categories: those that have a weak appetite or those that have a fast ... to gain weight, CB-1 Weight Gainer gives three tips for slowing down metabolism. , The ...
(Date:9/3/2015)... ... 03, 2015 , ... Doctor Kayode Sotonwa can be counted on ... perspective on internal medicine keeps patients happy and healthy, something that is important to ... the season, but even more so in the fall, when holiday eating and seasonal ...
(Date:9/2/2015)... (PRWEB) , ... September 03, 2015 , ... One can ... with higher frequency than they do laptops and personal computers. These devices are being ... the evolution and the revolution of mobile dating apps, STD positive singles can now ...
(Date:9/2/2015)... ... September 02, 2015 , ... ... Symposium (WFS), cosponsored by the Military Officers Association of America (MOAA) and ... "Our Nation's Military: Caring For Our Own,” expert panelists will lead interactive ...
Breaking Medicine News(10 mins):Health News:The Romantic Comedy Film "Love in Tokyo" Has Been Released on ITunes, Google Play, and Amazon 2Health News:CB-1 Weight Gainer Gives Three Tips for Slowing Down Metabolism 2Health News:CB-1 Weight Gainer Gives Three Tips for Slowing Down Metabolism 3Health News:Doctor Kayode Sotonwa Highlights Expert Tips for Staying in Shape This Fall 2Health News:Herpes-datingsites.com Recently Added Reviews of 5 STD Dating Apps for STD Positive Singles 2Health News:MOAA and WWP host 2015 Warrior-Family Symposium Chairman of the Senate Committee on Veterans' Affairs and the Secretary of Veterans Affairs to Speak 2Health News:MOAA and WWP host 2015 Warrior-Family Symposium Chairman of the Senate Committee on Veterans' Affairs and the Secretary of Veterans Affairs to Speak 3
... March 25 KV Pharmaceutical Company,(NYSE: KVA/KVB), ... manufactures, acquires and markets technology differentiated,branded and ... its fiscal 2007 Form 10-K with the ... restatements of previously reported results for,fiscal years ...
... In a ceremony,attended by Ohio,s physician leaders, ... of the most sweeping physician-insurance industry,contract reform bills ... law, which will take effect in ninety days, ... the contracting process,fairness in contracting, and a standardized ...
... Evalve, Inc., the leader,in the development of devices ... Mark approval for its MitraClip(R) system. The,MitraClip is the ... patients suffering from the effects of mitral,regurgitation (MR)., ... insufficiency in the United,States and the second most common ...
... Inc. (Nasdaq: MAPP ) today announced the ... board of directors. Mr. Wolff,brings over 25 years ... will,also serve on the audit committee., Mr. ... Financial,Officer at Richmond, Calif.-based Sangamo BioSciences, Inc. where ...
... recurrence and new malignancies surfaced , , TUESDAY, March 25 ... concerning women and hormone replacement therapy: Not only do ... while taking the therapy, breast cancer survivors who do ... or a new malignancy. , "This is the first ...
... has been,appointed as the Richard Merkin Distinguished Professor ... Richard Merkin, President of,Heritage Provider Network and avid ... of his endowment because of his passion for ... increasingly dependant on,mathematics. Math is the fabric with ...
Cached Medicine News:Health News:KV Pharmaceutical Company Completes Financial Restatement with the Filing of Fiscal 2007 Form 10-K 2Health News:KV Pharmaceutical Company Completes Financial Restatement with the Filing of Fiscal 2007 Form 10-K 3Health News:KV Pharmaceutical Company Completes Financial Restatement with the Filing of Fiscal 2007 Form 10-K 4Health News:Governor Strickland Signs House Bill 125 Into Law 2Health News:Correction: Evalve Announces CE Mark Approval of the World's First Percutaneous Valve Repair System 2Health News:Correction: Evalve Announces CE Mark Approval of the World's First Percutaneous Valve Repair System 3Health News:Correction: Evalve Announces CE Mark Approval of the World's First Percutaneous Valve Repair System 4Health News:MAP Pharmaceuticals Appoints H. Ward Wolff to Board of Directors 2Health News:HRT Raises Recurrence Risk Among Breast Cancer Survivors 2Health News:Danny Calegari Appointed the Richard Merkin Distinguished Professor of Mathematics at the California Institute of Technology 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: